Literature DB >> 23558212

Purtscher retinopathies: are we aiming at the wrong target?

I H Yusuf, S-L Watson.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23558212      PMCID： PMC3682354          DOI： 10.1038/eye.2013.47

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

Review 1.  Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13.

Authors:  Kent Chapman; Michael Seldon; Ross Richards
Journal:  Semin Thromb Hemost       Date:  2012-02-07       Impact factor: 4.180

2.  ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.

Authors:  Jake Shortt; Danielle H Oh; Stephen S Opat
Journal:  N Engl J Med       Date:  2013-01-03       Impact factor: 91.245

3.  Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.

Authors:  J J J Hulstein; P J van Runnard Heimel; A Franx; P J Lenting; H W Bruinse; K Silence; Ph G de Groot; R Fijnheer
Journal:  J Thromb Haemost       Date:  2006-09-12       Impact factor: 5.824

4.  ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura.

Authors:  G Bettoni; R Palla; C Valsecchi; D Consonni; L A Lotta; S M Trisolini; I Mancini; K M Musallam; F R Rosendaal; F Peyvandi
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

Review 5.  Systematic review of Purtscher's and Purtscher-like retinopathies.

Authors:  A I M Miguel; F Henriques; L F R Azevedo; A J R Loureiro; D A L Maberley
Journal:  Eye (Lond)       Date:  2012-11-23       Impact factor: 3.775
  5 in total
  3 in total

1.  Response to Yusuf and Watson.

Authors:  A I M Miguel; F Henriques; L F R Azevedo; A J R Loureiro; D A L Maberley
Journal:  Eye (Lond)       Date:  2013-04-05       Impact factor: 3.775

2.  Purtscher-like retinopathy associated with squamous cell carcinoma of the cervix.

Authors:  Darren Shu Jeng Ting; Jonathan Smith; Stephen James Talks
Journal:  Int Ophthalmol       Date:  2017-02-06       Impact factor: 2.031

3.  Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome.

Authors:  J E Ramos de Carvalho; R O Schlingemann; M Oranje; F J Bemelman; M J van Schooneveld
Journal:  Int Ophthalmol       Date:  2017-03-08       Impact factor: 2.031
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.